- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00725166
Human Muscle Gene Expression Profiles in Young and Old Men (CERA)
To reach the goals of living longer in better medical conditions, many countries reach the same conclusion: new strategies have to be developed to avoid, or at least limit, the effects of age; this requires a better knowledge of the mechanisms of aging. Our project focuses on the loss of muscle mass associated with aging, called sarcopenia. Sarcopenia unavoidably leads to impaired mobility and poor balance, which contributes to loss of functional autonomy and to increased prevalence for severe falls. Skeletal muscle also plays a central role as a reserve for energy and amino acids. Hence, sarcopenia further triggers severe side metabolic effects such as frailty among elderly persons. The precise mechanisms of muscle aging are still mostly unknown, although many theories have been proposed.
The present study aims at better understanding the mechanisms of skeletal muscle loss associated with aging. Using muscle biopsies from young and old subjects, the differential expression profiles of mRNA will be obtained through chips that will evaluate more than 39000 transcripts. On the same samples, proteomic analyses will involve two complementary approaches: (1) bidimensional electrophoresis (2DGE) coupled to mass spectrometry (MALDI-ToF) for dominant proteins; (2) Western-blot (more than 800 antibodies) targeting regulating proteins not detectable using 2DGE. Complementary histological studies (immunohisto-fluorescence, confocal microscopy) will specify the localisation of the major biomarkers in the muscle biopsies.
The results of that research will have applications in the medium term and will lead to nutritional interventions to modulate specific metabolic pathways and improve the quality of life in the elderly.
Studieoversikt
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Saint-etienne, Frankrike, 42000
- CHU de Saint-Étienne
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Affiliated or beneficiary of a social security category
- Having signed the inform consent form
- Having signed the genetic consent form
Exclusion Criteria:
- Antiaggregant platelet treatment
- Type 2 diabetes
- Body Mass Index > 25
- Severe renal disease
- CRP > 10
- Abnormal clotting test
- Allergies to local anesthetics
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Young
Young men 19-25 years old
|
W1 - Blood test
W2 - Maximal metabolic test using a cycloergometer W3 - Muscular biopsy |
|
Old
old men 70-76 years old, who participate in the PROOF study (NCT 00759304)
|
W1 - Blood test
W2 - Maximal metabolic test using a cycloergometer W3 - Muscular biopsy |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
To identify the differential expression profiles (proteomics, transcriptomics) in skeletal muscle between young and old men
Tidsramme: During biopsie (W3)
|
During biopsie (W3)
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
To specify the localisation of the major biomarkers in the muscle biopsies.
Tidsramme: During biopsie (W3)
|
During biopsie (W3)
|
|
To compare muscular energy metabolic enzymatic activities between young and old men
Tidsramme: during biopsie (W3)
|
during biopsie (W3)
|
|
To compare the number of muscular stem cells between young and old men
Tidsramme: during biopsie (W3)
|
during biopsie (W3)
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Studiestol: Daniel BECHET, PhD, INRA Clermont-Ferrand
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 0708102
- 2008-A00374-51
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .